Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Applying to START South Texas Accelerated Research Therapeutics · San Antonio, Texas
Answer a few short questions to share with the research team.